Jamjoom Pharmaceuticals Factory Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Tarek Youssef Hosni
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.8yrs |
| CEO ownership | n/a |
| Management average tenure | 3yrs |
| Board average tenure | 2.5yrs |
CEO
Tarek Youssef Hosni (60 yo)
3.8yrs
Tenure
Mr. Tarek Youssef Hussein Hosni serves as Chief Executive Officer of Jamjoom Pharmaceuticals Factory Company since February 15, 2021. He has served as the Member of the Board of Directors at Ultra Group Co...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 3.8yrs | no data | no data | |
| Vice Chairman | 10.9yrs | no data | 4.55% SAR 496.9m | |
| Chief Financial Officer | 11.9yrs | no data | no data | |
| Head of Business Operations & Operations Director | 3.3yrs | no data | no data | |
| Head of Business Development & Strategy and IR Director | no data | no data | no data | |
| Head of the Legal Department & Group Legal Director | 2.6yrs | no data | no data | |
| Human Resources Director | 2.8yrs | no data | no data | |
| Head of Manufacturing Operations | 2.8yrs | no data | no data | |
| Board Secretary | 3yrs | no data | no data |
3.0yrs
Average Tenure
40yo
Average Age
Experienced Management: 4015's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman | 10.9yrs | no data | 4.55% SAR 496.9m | |
| Non-Executive Director | 2.5yrs | no data | 0.000010% SAR 1.1k | |
| Chairman | 2.5yrs | no data | 5.6% SAR 611.5m | |
| Non-Executive Director | 19.9yrs | no data | 41.65% SAR 4.5b | |
| Non-Executive Director | 2.5yrs | no data | 4.55% SAR 496.9m | |
| Non-Executive Director | 2.5yrs | no data | 4.55% SAR 496.9m | |
| Non-Executive Independent Director | 2.5yrs | no data | no data | |
| Non-Executive Independent Director | 2.5yrs | no data | no data | |
| Non-Executive Independent Director | 2.5yrs | no data | no data |
2.5yrs
Average Tenure
52yo
Average Age
Experienced Board: 4015's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 22:29 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jamjoom Pharmaceuticals Factory Company is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Madhu Appissa | Al Rajhi Capital |
| null null | J.P. Morgan |
| Tarek Sleiman | J.P. Morgan |